Madam Speaker, I thank my hon. colleague for the information, but that is just not how it is working.
It is not working because companies will not apply. They are not going to apply to Canada because of those proposed regulations. That is why the numbers of companies applying has gone down 60%. Companies are not going to bring it here.
The problem is the member can say it is going faster, but it is not, because the companies have not applied.
We have people dying when 90% of cystic fibrosis people could survive. The cost to our health care system is phenomenal. These people are going to ERs because of their medical conditions. It is a huge cost. They could have a life, and 90% of the cases for CF patients could be resolved from this particular drug.
We need this done now.